PT1290012E - Derivados amida do acido 2-amino-3-hidroxi-4-tert-leucil-amino-5-fenil-pentanoico - Google Patents

Derivados amida do acido 2-amino-3-hidroxi-4-tert-leucil-amino-5-fenil-pentanoico

Info

Publication number
PT1290012E
PT1290012E PT01943442T PT01943442T PT1290012E PT 1290012 E PT1290012 E PT 1290012E PT 01943442 T PT01943442 T PT 01943442T PT 01943442 T PT01943442 T PT 01943442T PT 1290012 E PT1290012 E PT 1290012E
Authority
PT
Portugal
Prior art keywords
amino
leucyl
tert
hydroxy
phenyl
Prior art date
Application number
PT01943442T
Other languages
English (en)
Portuguese (pt)
Inventor
Pascal Furet
Carlos Garcia-Echeverria
Imbach Patricia
Marc Lang
Johann Zimmermann
Original Assignee
Novartis Ag
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Novartis Pharma Gmbh filed Critical Novartis Ag
Publication of PT1290012E publication Critical patent/PT1290012E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT01943442T 2000-05-25 2001-05-23 Derivados amida do acido 2-amino-3-hidroxi-4-tert-leucil-amino-5-fenil-pentanoico PT1290012E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0012795.1A GB0012795D0 (en) 2000-05-25 2000-05-25 Organic compounds

Publications (1)

Publication Number Publication Date
PT1290012E true PT1290012E (pt) 2006-09-29

Family

ID=9892401

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01943442T PT1290012E (pt) 2000-05-25 2001-05-23 Derivados amida do acido 2-amino-3-hidroxi-4-tert-leucil-amino-5-fenil-pentanoico

Country Status (11)

Country Link
US (2) US20030166572A1 (cg-RX-API-DMAC10.html)
EP (1) EP1290012B1 (cg-RX-API-DMAC10.html)
JP (1) JP2003533541A (cg-RX-API-DMAC10.html)
AT (1) ATE325809T1 (cg-RX-API-DMAC10.html)
AU (1) AU2001266019A1 (cg-RX-API-DMAC10.html)
CA (1) CA2405871A1 (cg-RX-API-DMAC10.html)
DE (1) DE60119514T2 (cg-RX-API-DMAC10.html)
ES (1) ES2261422T3 (cg-RX-API-DMAC10.html)
GB (1) GB0012795D0 (cg-RX-API-DMAC10.html)
PT (1) PT1290012E (cg-RX-API-DMAC10.html)
WO (1) WO2001089282A2 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040762A1 (es) * 2002-11-27 2004-11-06 Elan Pharm Inc Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer
GB0504950D0 (en) * 2005-03-10 2005-04-20 Novartis Ag Organic compositions
US7919468B2 (en) 2005-04-07 2011-04-05 Centre National De La Recherche Scientifique (C.N.R.S.) Compounds useful as modulators of the proteasome activity
JP2011513278A (ja) * 2008-02-28 2011-04-28 ノバルティス アーゲー カンナビノイド受容体結合化合物およびオピオイドを含む組合せ
EP2399129B1 (en) 2009-02-20 2015-11-25 Michael P. Lisanti A method of diagnosis or prognosis of a neoplasm comprising determining the level of expression of a protein in stromal cells adjacent to the neoplasm
GB2523211B (en) 2012-01-27 2020-03-18 Univ Jefferson MCT protein inhibitor-related prognostic and therapeutic methods
EP2986290A4 (en) 2013-04-19 2017-01-04 Thomas Jefferson University Caveolin-1 related methods for treating glioblastoma with temozolomide
WO2019231935A1 (en) * 2018-05-29 2019-12-05 Omeros Corporation Masp-2 inhibitors and methods of use
AU2020395306B2 (en) 2019-12-04 2025-04-24 Omeros Corporation MASP-2 inhibitors and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538997A (en) * 1993-03-12 1996-07-23 Sandoz Ltd. 2,4-diamino-3-hydroxycarboxylic acid derivatives
EP0982317A1 (en) * 1998-08-26 2000-03-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Bivalent inhibitors of the proteasome
ATE270268T1 (de) * 1999-04-27 2004-07-15 Novartis Pharma Gmbh 2,4-diamino-3-hydroxycarboxylsäurederivate als proteasome inhibitoren

Also Published As

Publication number Publication date
AU2001266019A1 (en) 2001-12-03
US20030166572A1 (en) 2003-09-04
EP1290012A2 (en) 2003-03-12
JP2003533541A (ja) 2003-11-11
WO2001089282A3 (en) 2002-05-10
US20060205673A1 (en) 2006-09-14
GB0012795D0 (en) 2000-07-19
EP1290012B1 (en) 2006-05-10
WO2001089282A2 (en) 2001-11-29
DE60119514D1 (de) 2006-06-14
DE60119514T2 (de) 2006-10-05
ATE325809T1 (de) 2006-06-15
ES2261422T3 (es) 2006-11-16
CA2405871A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
MXPA04000577A (es) Derivados de dolastatina 10.
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
ATE361287T1 (de) Neue indol-2-on derivate
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
MXPA03005464A (es) Agentes antivirales.
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
CY1108871T1 (el) Υποκατεστημενα παραγωγα αμινο-φουραν-2-υλ-οξεικου οξεος και αμινο-θειεν-2-οξεικου οξεος και η χρησιμοποιηση τους για τη θεραπεια ημικρανιας ή πονου
SE0102439D0 (sv) New compounds
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
SE0101387D0 (sv) Novel compounds
MXPA05011076A (es) Derivados de quinazolina para el tratamiento de cancer.
MXPA04004601A (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
BR0315580A (pt) Derivados de metileno uréia
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
SE0100569D0 (sv) New compounds
TW200505452A (en) Chemical compounds
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
ATE367387T1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
SE9804212D0 (sv) Compounds
MXPA05010020A (es) Derivados de oxamida.
SE0102440D0 (sv) New compound
ATE325809T1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure